33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Combination therapy with nivolumab and tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma
    Meeting Abstract

    Garmezy, B.; Zhang, T.; Laccetti, A. L.; Economides, M. P.; Shah, A. Y.; Tannir, N. M.; Jonasch, E.; Msaouel, P.; Zurita, A. J.; Corn, P. G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • TRIDENT-1: A global, multicenter, open-label Phase II study investigating the activity of repotrectinib in advanced solid tumors harboring ROS1 or NTRK1-3 rearrangements
    Meeting Abstract

    Doebele, R. C.; Lin, J. J.; Nagasaka, M.; Zhu, V. W.; Gabrail, N. Y.; Bazhenova, L.; Anderson, P. M.; Solomon, B. J.; Dudek, A. Z.; Pippas, A. W.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase I study of Aurora kinase A inhibitor LY3295668 erbumine as a single agent and in combination in patients with relapsed/refractory neuroblastoma
    Meeting Abstract

    DuBois, S. G.; Kremer, J. D.; De Wilde, B.; Jacobsen, C.; Aerts, I.; Mosse, Y. P.; Maris, J. M.; Lithio, A.; Gosberg, A.; Banks, C. L.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A retrospective analysis of cost and survival outcomes based on consolidation regimens in primary central nervous system lymphoma
    Meeting Abstract

    Gelhard, S.; Maxwell, A.; Colman, H.; Cohen, A. L.; Mendez, J. S.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Symptomatic delayed seromas vs incidental findings on MR, and likelihood of BIA-ALCL in women with textured implants
    Meeting Abstract

    Ghione, P.; Sutton, E. J.; Hu, Q.; Galasso, N.; Ganesan, N.; Tyagi, N.; Martinez, D. F.; Dogan, A.; Morris, E. A.; Horwitz, S. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Hepatic arterial infusion (HAI) chemotherapy via the medtronic pump-assessing dose delivery, response rates and toxicity
    Meeting Abstract

    Connell, L. C.; Fiedler, L.; Dickinson, S.; Ly, M.; Harrington, K.; Jarnagin, W. R.; Kingham, T. P.; Drebin, J. A.; Balachandran, V. P.; Wei, A. C.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Family building preferences among young women with invasive breast cancer
    Meeting Abstract

    Crown, A.; Abdo, N.; Noy, A.; Chang, C.; Gemignani, M.; Goldfarb, S. B.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Updated 5-year local control (LC), metastasis-free survival (MFS), and overall survival (OS) data from a phase I study of nilotinib plus radiation (RT) in high-risk chordoma
    Meeting Abstract

    Cote, G. M.; DeLaney, T. F.; Miao, R.; Schwab, J. H.; Raskin, K.; Calderon, S. L.; Mullen, J. T.; Haynes, A. B.; Hornicek, F. J.; Chen, Y. L.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Safety and activity of autologous T cells with enhanced NY-ESO-1-specific T-cell receptor (GSK3377794) in HLA-a*02(+) previously-treated and - untreated patients with advanced metastatic/unresectable synovial sarcoma: A master protocol study design (IGNYTE-ESO)
    Meeting Abstract

    D'Angelo, S. P.; Blay, J. Y.; Chow, W. A.; Demetri, G. D.; Thistlethwaite, F.; Sen, S.; Razak, A. R. A.; Haanen, J. B. A. G.; Noujaim, J. C.; Johnson, M. L.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Evaluation of immune-related adverse events (irAE): Utilizing the patient-reported outcomes of the common terminology criteria for adverse events (PRO-CTCAE) in a phase II study of ipilimumab (ipi) in men with castration-sensitive prostate cancer (CSPC)
    Meeting Abstract

    Vargas Pivato de Almeida, D.; Anderson, J.; Danila, D. C.; Morris, M. J.; Slovin, S. F.; Abida, W.; Dayan, E. S.; Curley, T.; Arauz, G.; Baser, R. E.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save